Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat and Anastrozole in Triple Negative Breast Cancer
NCT01234532Phase 2Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2010
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in triple-negative breast cancer (TNBC), sponsored by University of Maryland, Baltimore. Started Oct 2010; status: terminated.
02
Drugs
entinostat
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01234532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01234532.